Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. November 2025 09:55 ET | Quelle: Research and Markets

Hepatorenal Syndrome Analysis and Forecast Report 2025-2035: Market Led by Mallinckrodt, Noorik, BioVie, and Ferring as Innovation, Partnerships, and Market Expansion Drive Competitive Growth

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Hepatorenal Syndrome Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
21. März 2025 06:00 ET | Quelle: Yaqrit

Yaqrit secures NIHR grant for pivotal trials of its liver support device, DIALIVE, for patients with liver failure

NIHR grant funds pivotal trial for Yaqrit's liver support device, DIALIVE, with potential to resolve life-threatening condition and impact survival.
11. Juli 2023 07:00 ET | Quelle: CytoSorbents

CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease

PRINCETON, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
25. Oktober 2017 16:01 ET | Quelle: Vital Therapies, Inc.

Vital Therapies Announces Third Quarter 2017 Financial Results

SAN DIEGO, Oct. 25, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...